Inactive Instrument

News GENFIT Euronext Paris

Equities

FR0004163111

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

06-28	European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading	MT
06-27	European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading	06-28	MT
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	06-27	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday But End Week Higher	06-21	MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Thursday Trading	06-20	MT
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	06-18	MT
GENFIT: New EASL EASD EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At Risk MASH	06-18	PU
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH	06-17	GL
European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	06-14	MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading	06-12	MT
European Equities Traded in the US as American Depositary Receipts Trend Sharply Lower in Tuesday Trading	06-11	MT
HC Wainwright Raises Genfit SA Price Target to $13 From $11, Maintains Buy Rating	06-11	MT
Genfit S.A. Announces the Successful Corporate Milestone with U.S. FDA Accelerated Approval of Ipsen's Iqirvo for Primary Biliary Cholangitis	06-11	CI
Genfit Partner Ipsen Gets FDA Accelerated Approval for Primary Biliary Cholangitis Treatment	06-10	MT
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis	06-10	GL
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug	06-10	RE
US FDA approves Genfit and Ipsen's liver disease drug	06-10	RE
European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading	06-10	MT
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading	06-07	MT
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	06-05	MT
GENFIT : Articles of Association updated on May 22, 2024	06-03	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GENFIT Euronext Paris

Equities

FR0004163111

Summary

Filters